Pseudomonads are the only organisms so far known to produce two lipoamide dehydrogenases (LPDs), LPD-Val and LPD-Glc. LPD-Val is the specific E3 component of branched-chain oxoacid dehydrogenase, and LPD-Glc is the E3 component of 2-ketoglutarate and possibly pyruvate dehydrogenases and the L-factor of the glycine oxidation system. Three mutants of Pseudomonas putida, JS348, JS350, and JS351, affected in lpdG, the gene encoding LPD-Glc, have been isolated; all lacked 2-ketoglutarate dehydrogenase, but two, JS348 and JS351, had normal pyruvate dehydrogenase activity. The pyruvate and 2-ketoglutarate dehydrogenases of the wild-type strain of P. putida were both inhibited by anti-LPD-Glc, but the pyruvate dehydrogenase of the lpdG mutants was not inhibited, suggesting that the mutant pyruvate dehydrogenase E3 component was different from that of the wild type. The lipoamide dehydrogenase present in one of the lpdG mutants, JS348, was isolated and characterized. This lipoamide dehydrogenase, provisionally named LPD-3, differed in molecular weight, amino acid composition, and N-terminal amino acid sequence from LPD-Glc and LPD-Val. LPD-3 was clearly a lipoamide dehydrogenase as opposed to a mercuric reductase or glutathione reductase. LPD-3 was about 60% as effective as LPD-Glc in restoring 2-ketoglutarate dehydrogenase activity and completely restored pyruvate dehydrogenase activity in JS350. These results suggest that LPD-3 is a lipoamide dehydrogenase associated with an unknown multienzyme complex which can replace LPD-Glc as the E3 component of pyruvate and 2-ketoglutarate dehydrogenases in lpdG mutants.
Most organisms produce only one lipoamide dehydrogenase, which is the E3 component of the keto acid dehydrogenase multienzyme complexes, pyruvate, 2-ketoglutarate, and branched-chain ketoacid dehydrogenases. The pyruvate and 2-ketoglutarate dehydrogenases of Escherichia coli have a common E3 component which is encoded by the Ipd gene. The Ipd gene is closely associated with aceE and aceF, the structural genes for the El and E2 components of pyruvate dehydrogenase, but is separated from aceF by 324 bases (18) . Expression of lpd occurs either in conjunction with that of aceE and aceF (17) or separately from its own promoter (18) . Mutants of E. coli affected in the expression of Ipd lose both pyruvate and 2-ketoglutarate dehydrogenase activities (7) . Evidence from the study of the human genetic disease lactic acidosis supports the belief that humans also possess a single lipoamide dehydrogenase. The defect in this disease is in the formation of lipoamide dehydrogenase, and these patients are deficient in pyruvate, 2-ketoglutarate, and branched-chain ketoacid dehydrogenases (12, 21) .
Given the above background, it was surprising to find that Pseudomonas putida and Pseudomonas aeruginosa were capable of forming two lipoamide dehydrogenases (LPDs), LPD-Glc and LPD-Val (10, 14) . LPD-Glc was the only lipoamide dehydrogenase found in P. putida grown in glucose synthetic medium, while both LPD-Glc and LPD-Val were recovered from cells grown in valine-containing medium. The two lipoamide dehydrogenases not only differed in physical properties such as molecular weight, amino acid composition, and UV spectrum (4, 10, 14) but were encoded by separate genes (16, 19) . They also differed in function: LPD-Val was the specific E3 component of branched-chain ketoacid dehydrogenase, while LPD-Glc was the E3 component of 2-ketoglutarate and probably pyruvate dehydrogenases (16) and the L-factor of the glycine oxidation system (13) . The structural gene for LPD-Val was found to be part of a tightly linked operon encoding all the components of the branched-chain ketoacid dehydrogenase complex (20) . The nucleotide sequence of the LPD-Val gene has been determined and compared with the sequences of other lipoamide dehydrogenases (G. Burns, T. Brown, K. Hatter, and J. R. Sokatch, Eur. J. Biochem., in press).
During the study of the chromosomal location of genes encoding the components of pyruvate, 2-ketoglutarate, and branched-chain ketoacid dehydrogenases of P. putida, a mutant was isolated which was affected in lpdG, the structural gene for LPD-Glc (19) . This mutant, P. putida JS348, lacked 2-ketoglutarate dehydrogenase, as expected, but had a normal amount of pyruvate dehydrogenase. The behavior of JS348 suggested the possibility of a third lipoamide dehydrogenase in P. putida. The objective of the present research was to explain the presence of pyruvate dehydrogenase activity in P. putida JS348. This communication reports the isolation of two additional lpdG mutants, their behavior, and isolation of a third lipoamide dehydrogenase from P. putida JS348.
MATERIALS AND METHODS
Bacterial strains and media. P. putida PpG2 is a wild-type strain which was originally obtained from I. C. Gunsalus.
Strain JS348 was isolated after treatment of P. putida PpG2 with nitrosoguanidine by selection for mutants unable to grow in medium with 2-ketoglutarate as the carbon source (19) . P. putida strains JS350 and JS351 were isolated in this study by the same procedure.
GAS medium (10 mM glucose, 2 mM acetate, and 2 mM succinate) was devised for mutants lacking both pyruvate and 2-ketoglutarate dehydrogenases, since these mutants frequently require acetate and succinate for growth (19) . Valine-isoleucine medium was described before (9) . Enzyme assays. The assays for pyruvate, 2-ketoglutarate, and branched-chain ketoacid dehydrogenases (15) and for lipoamide dehydrogenase (16) were described before. The assays for the El and E2 components of the ketoacid dehydrogenases were described before (16) .
Purification of LPD-3. LPD-3 was purified from 88.7 g of P. putida JS348 cells grown in GAS synthetic medium. The cells were suspended in two 150-ml batches of 50 mM potassium phosphate buffer containing 1 mM EDTA and 0.5 mM dithiothreitol (phosphate-EDTA-DTT buffer). The cell suspensions were sonicated for four 10- E2 and E3. The heat-treated fraction was dialyzed against two changes of 0.01 mM potassium phosphate (pH 7.0)-i mM EDTA-5 mM 2-mercaptoethanol. The dialyzed, heat-treated fraction (210 ml) was loaded onto an Affi-Gel Blue column (1.5 by 17 cm) equilibrated with 10 mM potassium phosphate (pH 7.0)-i mM EDTA-0.5 mM DTT. LPD-3 was eluted with a linear gradient of 0.0 to 0.5 M sodium chloride, again at about 0.25 to 0.35 M sodium chloride. Fractions (3 ml) were collected, and fractions 66 to 87 were pooled.
Methods used for characterization of LPD-3. The preparation of antibody against LPD-Glc was described before (16) . Methods for digestion of LPD-3 with chymotrypsin and electrophoresis in sodium dodecyl sulfate (SDS)-polyacrylamide gels were described before (3, 16) It was previously reported that JS348 lacked 2-ketoglutarate dehydrogenase but had normal levels of pyruvate dehydrogenase (19) ( Table 1 ). This was an unexpected finding, since lpd mutants of E. coli lack both pyruvate and 2-ketoglutarate dehydrogenases (7) . Additional lpdG mutants of P. putida were isolated to see whether the behavior of JS348 was atypical. One of the newly isolated lpdG mutants, JS350, did indeed lack pyruvate as well as 2-ketoglutarate dehydrogenase, but the other, JS351, was similar to JS348 ( Table 1 ). The pyruvate dehydrogenase activity of JS350 was restored by the addition of purified LPD-Glc (Table 1 ). This finding suggested that LPD-Glc was the E3 component of pyruvate as well as 2-ketoglutarate dehydrogenase. Furthermore, anti-LPD-Glc but not anti-LPD-Val inhibited both pyruvate and 2-ketoglutarate dehydrogenases of the wildtype strain, P. putida PpG2 (Table 1) , which seemed to strengthen this conclusion. However, anti-LPD-Glc did not inhibit the pyruvate dehydrogenase of JS348 or JS351, which suggested that there was a third lipoamide dehydrogenase in P. putida which was being used by JS348 and JS351 as the E3 component of pyruvate dehydrogenase. If this were the case, however, it is not obvious why JS350 lacks pyruvate dehydrogenase. Since these mutants were obtained after nitrosoguanidine treatment, it is possible that JS350 has a second mutation which prevents the third lipoamide dehydrogenase from being assembled in the complex.
Purification and properties of LPD-3. The lipoamide dehydrogenase in JS348 was provisionally named LPD-3. LPD-3 was isolated from pyruvate dehydrogenase of JS348 and The amino acid composition of LPD-3, not shown here, was clearly different from that of LPD-Val but similar to that of LPD-Glc. Since the molecular weight of LPD-3 is lower than that of LPD-Glc, we considered the possibility that LPD-3 was a truncated version of LPD-Glc caused by premature termination. However, no precipitate was formed between LPD-3 and anti-LPD-Glc in Ouchterlony plates. The enzymatic activity of LPD-3 was not inhibited by anti-LPD-Glc under conditions in which LPD-Glc was inhibited 93%. When purified LPD-3 and LPD-Glc were digested with chymotrypsin, the patterns of peptides formed from the two proteins were very different, showing that LPD-Glc and LPD-3 were different proteins (Fig. 1) . A similar result was obtained with peptides from cyanogen bromide cleavage of LPD-3 and LPD-Glc.
Conclusive proof that LPD-Glc and LPD-3 are different proteins was obtained from comparison of amino acid sequences of their N-termini (Fig. 2 ). There were nine differ- ences in 23 amino acids, which clearly shows that these two proteins are the products of separate genes. This region of lipoamide dehydrogenase contains the binding site for the adenine of FAD, beginning at residue 6 of LPD-3, and is highly conserved in all five lipoamide dehydrogenases shown in Fig. 2 . The high degree of similarity in this region suggests that LPD-3 is a lipoamide dehydrogenase. The mercuric reductases of gram-negative bacteria are also redox-active disulfide flavoproteins, but are unlike the other proteins in this group since they have approximately 90 amino acid residues in front of the adenine-binding region (1, 2, 11) . Since LPD-3 lacks this N-terminal segment, it is unlikely to be a mercuric reductase.
Glutathione reductase is another redox-active disulfide flavoprotein which has distinct amino acid sequence similarity to E. coli lipoamide dehydrogenase (7) and LPD-Val (Burns et al., in press). Purified LPD-3 had no glutathione reductase activity, but glutathione reductase was detected in enzyme extracts of P. putida PpG2 at a specific activity of 50 nmol/min per mg of protein. Therefore, LPD-3 is not a glutathione reductase which has been recruited as a lipoarmide dehydrogenase.
Functions of LPD-3. Purified LPD-3 was used to complement keto acid dehydrogenase activity of the mutants used in this study in an attempt to identify the function of LPD-3. LPD-3 was as effective as LPD-Glc in restoring the pyruvate dehydrogenase activity of JS350 (Table 3) , but there was no clear-cut effect of LPD-3 on the pyruvate dehydrogenase of JS348 and JS351 (Table 3) . LPD-3 was also able to restore 2-ketoglutarate dehydrogenase activity to JS348, JS350, and JS351 but was only about 60% as effective as LPD-Glc. This result suggests that LPD-3 is not the natural E3 component of the 2-ketoglutarate dehydrogenase of P. putida.
DISCUSSION
The data in this study explain the anomalous behavior of JS348, provide further evidence about the function of LPD- (Table 3) agrees with this conclusion. In this respect, JS350 behaves like a typical E. coli lpd mutant (7) . However, the behavior of mutants JS348 and JS351 was unexpected, since they clearly have the lpdG mutation yet have nearly normal pyruvate dehydrogenase activity. Also, the lipoamide dehydrogenase isolated from JS348 was LPD-3, not LPD-Glc.
The question of the natural role of LPD-3 in P. putida is perplexing. Clearly LPD-3 is the product of a separate structural gene and not a truncated form of LPD-Glc or the result of a missense mutation. From the data in Tables 1 and  3 , it appears that LPD-3 acts in place of LPD-Glc in lpdG mutants. LPD-3 is apparently preferentially assembled with the pyruvate dehydrogenase in JS348 and JS351, since these mutants have pyruvate but not 2-ketoglutarate dehydrogenase activity. We expect that LPD-3 will prove to be rather closely related to LPD-Glc based on their amino acid compositions and the fact that LPD-3 can replace LPD-Glc to a large extent. Since LPD-3 is not as effective as LPD-Glc in complementing 2-ketoglutarate dehydrogenase activity in JS348 and JS351 (Table 3) , LPD-3 is probably not the E3 component of 2-ketoglutarate dehydrogenase. What then is the normal role of LPD-3? LPD-3 is almost certainly a lipoamide dehydrogenase because of the N-terminal sequence (Fig. 2) . Since LPD-Glc is the E3 component of 2-ketoglutarate and probably pyruvate dehydrogenases and the L-factor of the glycine oxidase complex (13) and LPDVal is the E3 component of branched-chain ketoacid dehydrogenase (10, 14; Burns et al., in press), that leaves very few possibilities for LPD-3. One possibility is that LPD-3 is the E3 component of 2-ketoadipate dehydrogenase. This complex has not been studied extensively, but it is used in the oxidation of D-lysine and pipicolic acid by pseudomonads (6) .
